We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

795 hedge funds and large institutions have $26B invested in Teva Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 268 increasing their positions, 324 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less call options, than puts

Call options by funds: $595M | Put options by funds: $620M

8% less first-time investments, than exits

New positions opened: 69 | Existing positions closed: 75

2% less funds holding

Funds holding: 812 → 795 (-17)

2.34% less ownership

Funds ownership: 58.38% → 56.04% (-2.3%)

13% less capital invested

Capital invested by funds: $30B → $26B (-$3.92B)

15% less funds holding in top 10

Funds holding in top 10: 41 → 35 (-6)

17% less repeat investments, than reductions

Existing positions increased: 268 | Existing positions reduced: 324

Holders
795
Holders Change
-17
Holders Change %
-2.09%
% of All Funds
21.21%
Holding in Top 10
35
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-14.63%
% of All Funds
0.93%
New
69
Increased
268
Reduced
324
Closed
75
Calls
$595M
Puts
$620M
Net Calls
-$24.3M
Net Calls Change
-$252M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$310M
2
Franklin Resources
Franklin Resources
California
+$295M
3
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss
Texas
+$202M
4
Capital Research Global Investors
Capital Research Global Investors
California
+$188M
5
JP Morgan Chase
JP Morgan Chase
New York
+$179M

Top Sellers

1
Viking Global Investors
Viking Global Investors
Connecticut
-$420M
2
PC
PointState Capital
New York
-$309M
3
HCM
Highfields Capital Management
Massachusetts
-$280M
4
IC
Institutional Capital
Illinois
-$217M
5
MIFH
Migdal Insurance & Financial Holdings
Israel
-$193M
Name Holding Trade Value Shares
Change 		Change in
Stake
IWA
651
Intercontinental Wealth Advisors
Texas
$216K -$2.14K -41 -0.9%
CWM
652
Concert Wealth Management
California
$216K +$5.79K +111 +2%
NAM
653
NTV Asset Management
West Virginia
$215K +$31.3K +600 +15%
ICOA
654
Investment Centers of America
North Dakota
$214K +$7.51K +144 +3%
MWM
655
Mission Wealth Management
California
$213K +$5.22K +100 +2%
S
656
SignatureFD
Georgia
$212K +$22.9K +438 +11%
JFA
657
JNBA Financial Advisors
Minnesota
$212K +$157K +3,009 +189%
GAAM
658
Guinness Atkinson Asset Management
California
$210K -$19.8K -380 -8%
WTC
659
WhitTier Trust Company
Nevada
$209K -$49.8K -955 -17%
IIM
660
Ivory Investment Management
New York
$209K +$26.1K +501 +12%
SFG
661
SevenBridge Financial Group
Pennsylvania
$209K +$80.9K +1,550 +49%
WRM
662
Westport Resources Management
Connecticut
$207K -$48.8K -935 -17%
KCM
663
Kanawha Capital Management
Virginia
$205K – – –
HAG
664
HighPoint Advisor Group
Illinois
$204K +$47.8K +916 +21%
BCMO
665
Buckingham Capital Management (Ohio)
Ohio
$203K -$20.9K -400 -8%
CLOS
666
Compagnie Lombard Odier SCmA
Switzerland
$172K -$193K -3,700 -50%
BC
667
Bartlett & Co
Ohio
$169K -$44K -844 -19%
EDRS
668
Edmond de Rothschild (Suisse)
Switzerland
$169K +$52.2K +1,000 +37%
CPP
669
Crow Point Partners
Massachusetts
$169K +$190K +3,646 New
CFG
670
CKW Financial Group
Hawaii
$168K +$190K +3,650 New
EWM
671
Elite Wealth Management
Washington
$166K +$188K +3,600 New
KT
672
Kanaly Trust
Texas
$165K -$91.4K -1,751 -33%
WAS
673
WESPAC Advisors SoCal
California
$163K – – –
MCM
674
MV Capital Management
Maryland
$163K -$25.1K -482 -12%
FCM
675
Forester Capital Management
Illinois
$158K – – –
25 26
27
28 29

TEVA Hedge Fund Activity: Q3 2016 in Review

795 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q3 2016, worth a combined $26B — down 13% from $30B a quarter earlier.

Sellers outnumbered buyers: 75 funds closed out of TEVA and 69 opened new positions — a net loss of 6 holders — while 324 trimmed existing stakes and 268 added.

The largest buyer was Morgan Stanley, adding an estimated $310M. The largest seller was Viking Global Investors, cutting an estimated $420M.

  • 795 institutional investors held Teva Pharmaceuticals (TEVA) as of Q3 2016, down from 812 in Q2 2016.
  • Funds reported $26B of Teva Pharmaceuticals stock for Q3 2016, down 13% quarter-over-quarter.
  • 69 funds opened new Teva Pharmaceuticals positions in Q3 2016 and 75 closed out, a net change of -6 holders.
  • The largest Teva Pharmaceuticals buyer in Q3 2016 was Morgan Stanley, an estimated $310M added.
  • The largest Teva Pharmaceuticals seller in Q3 2016 was Viking Global Investors, an estimated $420M sold.

Based on aggregated 13F filings for Q3 2016.